SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-069939
Filing Date
2021-05-20
Accepted
2021-05-20 16:36:01
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2117144-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2117144-5_4seq1.xml 4 4145
  Complete submission text file 0001104659-21-069939.txt   5678
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 399 THORNALL STREET, FIRST FLOOR EDISON NJ 08837
Business Address
Foster Robert T (Reporting) CIK: 0001677370 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 21944981